Pricing Log in Create free account

eXoZymes Inc. (EXOZ) vs 4D pharma PLC Sponsored ADR (LBPS)

eXoZymes Inc. and 4D pharma PLC Sponsored ADR are both Biotechnology companies. eXoZymes Inc. and 4D pharma PLC Sponsored ADR are of similar size ($37.2M and $37.1M). eXoZymes Inc. has the higher net margin (0.00% vs −2,010.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, 4D pharma PLC Sponsored ADR leads on 6 and eXoZymes Inc. on 5.

Valuation

Metric EXOZ LBPS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 211.23 9.71
P/B 9.69 9.49 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m — 0.64
EV/Sales n/m — 9.21
Earnings yield (29.10%) (40.76%) (33.15%)
Free cash flow yield (20.16%) (30.32%) (25.50%)

Profitability

Metric EXOZ LBPS Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (2,010.89%) 0.00%
Free cash flow margin 0.00% (3,283.80%) 0.00%
Return on equity (187.16%) (155.83%) (56.36%)
Return on assets (115.42%) (77.95%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EXOZ LBPS Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (22.47%) 35.04% 30.26%
Revenue growth, 5-year CAGR — 21.70% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EXOZ LBPS Biotechnology median
Debt to equity 0.01 0.43 0.00
Current ratio 3.81 5.21 4.72
Net debt to EBITDA 0.31 0.23 0.96

Dividend

Metric EXOZ LBPS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EXOZ LBPS Biotechnology median
Market cap 37.12m 37.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack